IBDEI20C ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32039,1,3,0)
;;=3^Nontoxic Diffuse Goiter
;;^UTILITY(U,$J,358.3,32039,1,4,0)
;;=4^E04.0
;;^UTILITY(U,$J,358.3,32039,2)
;;=^5002477
;;^UTILITY(U,$J,358.3,32040,0)
;;=E89.0^^126^1643^10
;;^UTILITY(U,$J,358.3,32040,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32040,1,3,0)
;;=3^Postprocedural Hypothyroidism
;;^UTILITY(U,$J,358.3,32040,1,4,0)
;;=4^E89.0
;;^UTILITY(U,$J,358.3,32040,2)
;;=^5003035
;;^UTILITY(U,$J,358.3,32041,0)
;;=D35.2^^126^1643^12
;;^UTILITY(U,$J,358.3,32041,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32041,1,3,0)
;;=3^Prolactinoma,Unspec Site
;;^UTILITY(U,$J,358.3,32041,1,4,0)
;;=4^D35.2
;;^UTILITY(U,$J,358.3,32041,2)
;;=^5002145
;;^UTILITY(U,$J,358.3,32042,0)
;;=Z13.1^^126^1643^13
;;^UTILITY(U,$J,358.3,32042,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32042,1,3,0)
;;=3^Screen,Diabetes
;;^UTILITY(U,$J,358.3,32042,1,4,0)
;;=4^Z13.1
;;^UTILITY(U,$J,358.3,32042,2)
;;=^5062700
;;^UTILITY(U,$J,358.3,32043,0)
;;=Z13.220^^126^1643^14
;;^UTILITY(U,$J,358.3,32043,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32043,1,3,0)
;;=3^Screen,Lipids
;;^UTILITY(U,$J,358.3,32043,1,4,0)
;;=4^Z13.220
;;^UTILITY(U,$J,358.3,32043,2)
;;=^5062702
;;^UTILITY(U,$J,358.3,32044,0)
;;=Z13.29^^126^1643^15
;;^UTILITY(U,$J,358.3,32044,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32044,1,3,0)
;;=3^Screen,Thyroid
;;^UTILITY(U,$J,358.3,32044,1,4,0)
;;=4^Z13.29
;;^UTILITY(U,$J,358.3,32044,2)
;;=^5062704
;;^UTILITY(U,$J,358.3,32045,0)
;;=R73.01^^126^1643^7
;;^UTILITY(U,$J,358.3,32045,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32045,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,32045,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,32045,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,32046,0)
;;=R73.02^^126^1643^8
;;^UTILITY(U,$J,358.3,32046,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32046,1,3,0)
;;=3^Impaired Glucose Tolerance
;;^UTILITY(U,$J,358.3,32046,1,4,0)
;;=4^R73.02
;;^UTILITY(U,$J,358.3,32046,2)
;;=^5019562
;;^UTILITY(U,$J,358.3,32047,0)
;;=R73.03^^126^1643^11
;;^UTILITY(U,$J,358.3,32047,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32047,1,3,0)
;;=3^Prediabetes
;;^UTILITY(U,$J,358.3,32047,1,4,0)
;;=4^R73.03
;;^UTILITY(U,$J,358.3,32047,2)
;;=^8295662
;;^UTILITY(U,$J,358.3,32048,0)
;;=N70.01^^126^1644^15
;;^UTILITY(U,$J,358.3,32048,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32048,1,3,0)
;;=3^Salpingitis,Acute
;;^UTILITY(U,$J,358.3,32048,1,4,0)
;;=4^N70.01
;;^UTILITY(U,$J,358.3,32048,2)
;;=^5015802
;;^UTILITY(U,$J,358.3,32049,0)
;;=A63.0^^126^1644^22
;;^UTILITY(U,$J,358.3,32049,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32049,1,3,0)
;;=3^Verereal Warts
;;^UTILITY(U,$J,358.3,32049,1,4,0)
;;=4^A63.0
;;^UTILITY(U,$J,358.3,32049,2)
;;=^5000360
;;^UTILITY(U,$J,358.3,32050,0)
;;=B37.3^^126^1644^1
;;^UTILITY(U,$J,358.3,32050,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32050,1,3,0)
;;=3^Candidiasis
;;^UTILITY(U,$J,358.3,32050,1,4,0)
;;=4^B37.3
;;^UTILITY(U,$J,358.3,32050,2)
;;=^5000615
;;^UTILITY(U,$J,358.3,32051,0)
;;=N72.^^126^1644^2
;;^UTILITY(U,$J,358.3,32051,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32051,1,3,0)
;;=3^Cervicitis
;;^UTILITY(U,$J,358.3,32051,1,4,0)
;;=4^N72.
;;^UTILITY(U,$J,358.3,32051,2)
;;=^5015812
;;^UTILITY(U,$J,358.3,32052,0)
;;=A74.89^^126^1644^3
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI20C 3784 printed Apr 09, 2024@21:49:49 Page 2
IBDEI20C ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32039,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,32039,1,3,0)
+4 ;;=3^Nontoxic Diffuse Goiter
+5 ;;^UTILITY(U,$J,358.3,32039,1,4,0)
+6 ;;=4^E04.0
+7 ;;^UTILITY(U,$J,358.3,32039,2)
+8 ;;=^5002477
+9 ;;^UTILITY(U,$J,358.3,32040,0)
+10 ;;=E89.0^^126^1643^10
+11 ;;^UTILITY(U,$J,358.3,32040,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,32040,1,3,0)
+14 ;;=3^Postprocedural Hypothyroidism
+15 ;;^UTILITY(U,$J,358.3,32040,1,4,0)
+16 ;;=4^E89.0
+17 ;;^UTILITY(U,$J,358.3,32040,2)
+18 ;;=^5003035
+19 ;;^UTILITY(U,$J,358.3,32041,0)
+20 ;;=D35.2^^126^1643^12
+21 ;;^UTILITY(U,$J,358.3,32041,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,32041,1,3,0)
+24 ;;=3^Prolactinoma,Unspec Site
+25 ;;^UTILITY(U,$J,358.3,32041,1,4,0)
+26 ;;=4^D35.2
+27 ;;^UTILITY(U,$J,358.3,32041,2)
+28 ;;=^5002145
+29 ;;^UTILITY(U,$J,358.3,32042,0)
+30 ;;=Z13.1^^126^1643^13
+31 ;;^UTILITY(U,$J,358.3,32042,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,32042,1,3,0)
+34 ;;=3^Screen,Diabetes
+35 ;;^UTILITY(U,$J,358.3,32042,1,4,0)
+36 ;;=4^Z13.1
+37 ;;^UTILITY(U,$J,358.3,32042,2)
+38 ;;=^5062700
+39 ;;^UTILITY(U,$J,358.3,32043,0)
+40 ;;=Z13.220^^126^1643^14
+41 ;;^UTILITY(U,$J,358.3,32043,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,32043,1,3,0)
+44 ;;=3^Screen,Lipids
+45 ;;^UTILITY(U,$J,358.3,32043,1,4,0)
+46 ;;=4^Z13.220
+47 ;;^UTILITY(U,$J,358.3,32043,2)
+48 ;;=^5062702
+49 ;;^UTILITY(U,$J,358.3,32044,0)
+50 ;;=Z13.29^^126^1643^15
+51 ;;^UTILITY(U,$J,358.3,32044,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,32044,1,3,0)
+54 ;;=3^Screen,Thyroid
+55 ;;^UTILITY(U,$J,358.3,32044,1,4,0)
+56 ;;=4^Z13.29
+57 ;;^UTILITY(U,$J,358.3,32044,2)
+58 ;;=^5062704
+59 ;;^UTILITY(U,$J,358.3,32045,0)
+60 ;;=R73.01^^126^1643^7
+61 ;;^UTILITY(U,$J,358.3,32045,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,32045,1,3,0)
+64 ;;=3^Impaired Fasting Glucose
+65 ;;^UTILITY(U,$J,358.3,32045,1,4,0)
+66 ;;=4^R73.01
+67 ;;^UTILITY(U,$J,358.3,32045,2)
+68 ;;=^5019561
+69 ;;^UTILITY(U,$J,358.3,32046,0)
+70 ;;=R73.02^^126^1643^8
+71 ;;^UTILITY(U,$J,358.3,32046,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,32046,1,3,0)
+74 ;;=3^Impaired Glucose Tolerance
+75 ;;^UTILITY(U,$J,358.3,32046,1,4,0)
+76 ;;=4^R73.02
+77 ;;^UTILITY(U,$J,358.3,32046,2)
+78 ;;=^5019562
+79 ;;^UTILITY(U,$J,358.3,32047,0)
+80 ;;=R73.03^^126^1643^11
+81 ;;^UTILITY(U,$J,358.3,32047,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,32047,1,3,0)
+84 ;;=3^Prediabetes
+85 ;;^UTILITY(U,$J,358.3,32047,1,4,0)
+86 ;;=4^R73.03
+87 ;;^UTILITY(U,$J,358.3,32047,2)
+88 ;;=^8295662
+89 ;;^UTILITY(U,$J,358.3,32048,0)
+90 ;;=N70.01^^126^1644^15
+91 ;;^UTILITY(U,$J,358.3,32048,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,32048,1,3,0)
+94 ;;=3^Salpingitis,Acute
+95 ;;^UTILITY(U,$J,358.3,32048,1,4,0)
+96 ;;=4^N70.01
+97 ;;^UTILITY(U,$J,358.3,32048,2)
+98 ;;=^5015802
+99 ;;^UTILITY(U,$J,358.3,32049,0)
+100 ;;=A63.0^^126^1644^22
+101 ;;^UTILITY(U,$J,358.3,32049,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,32049,1,3,0)
+104 ;;=3^Verereal Warts
+105 ;;^UTILITY(U,$J,358.3,32049,1,4,0)
+106 ;;=4^A63.0
+107 ;;^UTILITY(U,$J,358.3,32049,2)
+108 ;;=^5000360
+109 ;;^UTILITY(U,$J,358.3,32050,0)
+110 ;;=B37.3^^126^1644^1
+111 ;;^UTILITY(U,$J,358.3,32050,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,32050,1,3,0)
+114 ;;=3^Candidiasis
+115 ;;^UTILITY(U,$J,358.3,32050,1,4,0)
+116 ;;=4^B37.3
+117 ;;^UTILITY(U,$J,358.3,32050,2)
+118 ;;=^5000615
+119 ;;^UTILITY(U,$J,358.3,32051,0)
+120 ;;=N72.^^126^1644^2
+121 ;;^UTILITY(U,$J,358.3,32051,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,32051,1,3,0)
+124 ;;=3^Cervicitis
+125 ;;^UTILITY(U,$J,358.3,32051,1,4,0)
+126 ;;=4^N72.
+127 ;;^UTILITY(U,$J,358.3,32051,2)
+128 ;;=^5015812
+129 ;;^UTILITY(U,$J,358.3,32052,0)
+130 ;;=A74.89^^126^1644^3
